Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria

• DOI: 10.1007/s00467-011-1987-6
• Publication Date: 2011-08-27T18:09:45Z
• Authors: Víctor García-Nieto; Margarita Monge-Z...; Montserrat Gonzál...; María Isabel Luis...
• Keywords: Male; Adolescent; Hypercalciuria; Body Mass Index; 3. Good health; Thiazides; Bone Diseases, Metabolic; 03 medical and health sciences; 0302 clinical medicine; Bone Density; Humans; Female; Child

To determine the effect of thiazide treatment on bone mineral density (BMD) in children with idiopathic hypercalciuria (IH) and osteopenia, we reviewed the case notes of 22 children aged 11.7 ± 2.7 years diagnosed with IH and osteopenia who had received thiazides for 2.4 years. The data on this group were compared with those of 32 IH children with osteopenia aged 11.2 ± 2.7 years who had not received thiazide treatment. By the end of the follow-up period, the z-BMD had improved spontaneously in 23 of the 32 control children (72%) and in 12 of the 22 patients on thiazides (54%). Although treated patients had a higher body mass index (BMI) and a higher BMD following treatment, the differences became statistically negligible when these parameters were expressed as z-BMD or as bone mineral apparent density (BMAD). In contrast, within the control group, there were significant differences in BMAD and z-BMD at the end of the follow-up. Patients who had an improved z-BMD at the end of the treatment also showed an increase in their BMI. Based on these results, we conclude that thiazide treatment does not improve the z-BMD in children with IH. More than half of the children suffering from IH enrolled in our study showed a spontaneous improvement in their z-BMD, which was more evident when the initial BMAD was not low and when their BMI increased during the follow-up period.